MSB 3.21% $1.13 mesoblast limited

Morningstar increases MSC 100-IV probability of success from 60%...

  1. 5,487 Posts.
    lightbulb Created with Sketch. 8943
    Morningstar increases MSC 100-IV probability of success from 60% to 90% after FDA fast-track was granted.

    CHF program accounts for 41% of their fair value assessment of MSB, currently with a 15% probability of success factored into.

    Expect a material impact to valuations if CHF P3 interim is positive (due this Qtr).

    Morningstar valuation
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.